Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-α in a phase III trial: Final results and geographical analysis
D. Cella*, M. D. Michaelson, A. G. Bushmakin, J. C. Cappelleri, C. Charbonneau, S. T. Kim, J. Z. Li, R. J. Motzer
Dive into the research topics of 'Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-α in a phase III trial: Final results and geographical analysis'. Together they form a unique fingerprint.